VAERS reports by lot

Moderna COVID-19 lot 020L20A: VAERS reports

20 VAERS reports list lot 020L20A as a Moderna COVID-19 vaccine, received between 2021-01-14 and 2022-09-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
10%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal1118%
Injection-site / Local reaction1118%
General / Systemic (non-local)813%
Neurological711%
Cardiac / Cardiovascular711%
Dermatological (non-injection-site)610%
Gastrointestinal58%
Allergic / Anaphylactic23%
Respiratory23%
Autoimmune / Immune-mediated12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia4
New York2
Massachusetts2
District of Columbia2
Colorado2
New Jersey1
New Mexico1
Virginia1
California1
Tennessee1
Connecticut1
Louisiana1

Reports by month received

2021-012
2021-023
2021-031
2021-051
2021-086
2021-093
2021-121
2022-021
2022-041
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.